Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

RxSight, Inc. - Common Stock (NQ:RXST)

15.85 +0.87 (+5.81%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about RxSight, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024
From RxSight, Inc.
Via GlobeNewswire
Peeling Back The Layers: Exploring RxSight Through Analyst Insights
Via Benzinga
RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences
From RxSight, Inc.
Via GlobeNewswire
RxSight Stock Sees Relative Strength Rating Rise To 91
On Monday, RxSight stock earned a positive adjustment to its Relative Strength (RS) Rating, from 88 to 91. 
Via Investor's Business Daily
Deep Dive Into RxSight Stock: Analyst Perspectives (6 Ratings)
Via Benzinga
RxSight Analysts Slash Their Forecasts After Q2 Results
Via Benzinga
RXST Stock Earnings: RxSight Beats Revenue for Q2 2024
RXST stock results show that RxSight beat on revenue for the second quarter of 2024. 
Via InvestorPlace
RxSight Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
Via Benzinga
Lithia Motors To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We have all of the biggest pre-market stock movers that traders are going to want to read about on Tuesday! 
Via InvestorPlace
Why Palantir Technologies Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why RxSight (RXST) Shares Are Falling
RxSight shares are trading lower by 5.6% during Thursday's session. The company announced pricing of its $100 million proposed public offering of common stock. 
Via Benzinga
What 10 Analyst Ratings Have To Say About RxSight
Via Benzinga
Assessing RxSight: Insights From 8 Financial Analysts
Via Benzinga
RxSight, Inc. Reports Second Quarter 2024 Financial Results
From RxSight, Inc.
Via GlobeNewswire
The 3 Best Med Tech Stocks to Buy Now
Med tech firms are tremendously improving healthcare and making a great deal of money. Here are the three best med tech stocks to buy now. 
Via InvestorPlace
RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024
From RxSight, Inc.
Via GlobeNewswire
Johnson & Johnson Q2 Earnings Preview: Can New Drugs Lift Sagging Stock?
Johnson & Johnson has beaten earnings per share in more than 10 straight quarters. Will the trend continue in Q2? 
Via Benzinga
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
RxSight, Inc. To Participate in the Truist Securities Medtech Conference
From RxSight, Inc.
Via GlobeNewswire
Do You Have Your Eye On Vision Care Stocks?
For investors seeking stable and growing opportunities, eye care stocks are an attractive option. 
Via Talk Markets
RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. Announces Pricing of Public Offering of Common Stock
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. Announces Proposed Public Offering of Common Stock
From RxSight, Inc.
Via GlobeNewswire
RXST Stock Earnings: RxSight Beats EPS, Beats Revenue for Q1 2024
RXST stock results show that RxSight beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
RxSight, Inc. Reports First Quarter 2024 Financial Results
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. to Present at the Bank of America Healthcare Conference
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024
From RxSight, Inc.
Via GlobeNewswire
RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting
From RxSight, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.